Longitudinal analysis of bone microstructural changes under luseogliflozin treatment using second-generation High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT) in elderly patients with type 2 diabetes
Latest Information Update: 25 Oct 2024
At a glance
- Drugs Luseogliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Bone microstructural change under luseogliflozin treatment
Most Recent Events
- 19 Oct 2020 Status changed from not yet recruiting to recruiting.
- 05 May 2020 Trial design published in the Trials
- 05 Apr 2019 New trial record